The Role of Chemistry in Clinical Trials: The Big Expense & Lessons Learned

July 31, 2014
Drug Discovery Series Part 6 of 8

Bottle of spilled pills

The physicochemical and biopharmaceutic properties of a preclinical candidate are defined by the candidate’s structure which directly affects its transition into and ease of progression through drug development and clinical evaluation. Our speakers will discuss the many groups involved, what they do, why they do it and how the properties of the candidate impact decisions.

*Access to this recording is an exclusive benefit for ACS Members.

Benefits of Membership

  • ACS Webinars Archive: Every one of our 200+ past webinars available on demand
  • Save Money: Members receive discounts on meetings, development courses and more!
  • Access to SciFinder®: Members receive 25 complimentary SciFinder® research activities per year

The Fine Print

ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.


Graham Johnson

Jay Sisco
JM Sisco Pharma Consulting

John Morrison
Bristol-Myers Squibb